Trevigen DIVAA (活體新血管試驗套組) Cultrex® DIVAA™ Angiogenesis Starter Kit#3450-048-K太鼎生物科技有限公司(02)86609496 @ 太鼎生物科技/太鼎食安科技

Trevigen DIVAA (活體新血管試驗套組)

取代傳統Plug assay自體吸收問題

DIVAA是市面上唯一可以定量且具重覆性的活體內血管新生套組, 此套組利用血管新生試驗管(angioreactor), 將待測藥物與BME混合物填至試驗管,並稙入老鼠體內進行血管新生試驗.與傳統的Matrigel plug方法相比.BME混合物不會被自體吸收,因此除了定性外亦可同時定量血管新生的程度,試驗結果再現性高,人為誤差程度小….是做活體血管新生的最佳選擇

Cultrex^® DIVAA^™ Angiogenesis Starter Kit

The Directed In Vivo Angiogenesis Assay (DIVAA^™) is the first in vivo system for the study of angiogenesis that provides quantitative and reproducible results. With the onset of angiogenesis, cellular vascularization proceeds to invade the angioreactor, and as early as nine days post-implantation, there are enough cells to determine an effective dose response to angiogenic modulating factors. The sleek design of the patented angioreactor optimizes sensitivity and allows for up to four units per mouse, giving a more controlled experiment and decreasing the number of mice required for a study. The DIVAA Starter Kit was developed with new users in mind. This kit is ideal for optimizing assay conditions.

Features:	This kit includes pathogen Free BME which has been tested and cleared of a Battery of 31 pathogens and viruses including LDEV. Contact Trevigen for details.

Applications:	Quantitative in vivo angiogenesis analysis.

Components:	Part #	Component	Size
	3450-048-01	Angioreactors	48 units
	3450-048-02	Growth Factor Reduced BME PathClear	6 x 200 µl
	3450-048-03	Wash Buffer	25 ml
	3450-048-04	FGF-2	100 ng/10 µl
	3450-048-05	CellSperse™	15 ml
	3450-048-06	200X FITC-Lectin	250 µg/50 µl
	3450-048-07	25X FITC-Lectin Diluent	400 µl
	3450-048-08	Heparin Solution	10 µl
	3450-048-09	AngioRack™	each
	3450-048-B10	FGF-2(1800 ng)/VEGF(600 ng)	60 µl

	*Basement Membrane Extract (BME)

Storage:	Components are stored at -20°C and 4°C and room temperature.

Cultrex^® Basement Membrane Proteins and Kits

Basement Membrane Extract can be used for promotion and maintenance of a differentiated phenotype in a variety of cell cultures including primary epithelial cells, endothelial cells, and smooth muscle cells. It has been employed in angiogenesis assays, tumor cell invasion assays, and as a vehicle to augment the tumorigenicity of injected tumor cells in nude mice. Trevigen also offers PathClear^® BME which has been tested and cleared of 31 pathogens and viruses as well as bacteria and mycoplasma.

Basement Membrane Extract